Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Level 2.....limerickhook

RE: Level 2.....limerickhook

posted on Mar 11, 2006 11:19AM
“150+ companies - 5 = 145 left as a possible source of reocurring revenues - in worse case, less any loyalties IMHO ...”

This is true, but emphasis on “possible”. Reoccurring licensing revenue or future cash flow is much more favorable and a variable that “Successful” companies have in common. One time payments eventually end, whereas, reoccurring revenue continues as long as the company has the proper management in place. IMHO, the difference between a company built on “One Time Payments” vs. “Future Reoccurring Revenue”, is a company with a short lived PPS of $5-$7 vs. a company with a long term PPS of $20-$25. Just hoping for the best outcome here for all.

Share
New Message
Please login to post a reply